Head-to-Head Comparison of Sedation and Somnolence Among 37 Antipsychotics in Schizophrenia, Bipolar Disorder, Major Depression, Autism Spectrum Disorders, Delirium, and Repurposed in COVID-19, Infectious Diseases, and Oncology From the FAERS, 2004–2020

Objective: Antipsychotic compounds are known to induce sedation somnolence and have expanded clinical indications beyond schizophrenia to regulatory approval in bipolar disorder, treatment-resistant depression, and is being repurposed in infectious diseases and oncology. However, the medical science...

Descripción completa

Detalles Bibliográficos
Autores principales: Eugene, Andy R., Eugene, Beata, Masiak, Marek, Masiak, Jolanta Sylwia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027114/
https://www.ncbi.nlm.nih.gov/pubmed/33841149
http://dx.doi.org/10.3389/fphar.2021.621691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027114/
https://www.ncbi.nlm.nih.gov/pubmed/33841149
http://dx.doi.org/10.3389/fphar.2021.621691

Ejemplares similares